CEMI News and Press, Chembio Diagnostics Inc. From 12/06/21

Chembio Diagnostics (NASDAQ:CEMI) has submitted a De Novo/510(k) Request to the FDA for DPP SARS-CoV-2 Antigen test system. Shares down 1.7% premarket at $1.73. Chembio received an award from the BARDA to support development of a COVID-19 point-of-care antigen test system using its ...

HAUPPAUGE, N.Y., Dec. 06, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced that it has submitted a De Novo/510(k) Request to the U.S. Food and Drug Administration (FDA) for the...

Are These 3 Under $4 Penny Stocks Worth Buying in 2021? While finding cheap penny stocks can be a great way to make money in 2021, there are a few things that investors need to understand. First and foremost, penny stocks can and are usually quite risky. The volatility that we see w...

Chembio Diagnostics (NASDAQ:CEMI) gains 9.5% premarket after receiving South Africa Health Products Regulatory Authority (SAHPRA) approval for the DPP SARS-CoV-2 Antigen test, authorizing marketing and distribution of the test for use at the point-of-care by professional healthcare ...

HAUPPAUGE, N.Y., Nov. 29, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced receipt on November 26, 2021, of South Africa Health Products Regulatory Authority (SAHPRA) approval ...

New African Virus Variant Puts These Penny Stocks In The Spotlight Today What’s going on in the stock market today? Earlier this week, we were heading into the holiday nearing record-high levels. Countless penny stocks were red hot, and retail traders were reaping the rewards...

iSpecimen (NASDAQ:ISPC) +70% COVID-19 vaccine stocks surge on worries over new variant Allied Healthcare Products (NASDAQ:AHPI) +68%. Alpha Pro Tech (NYSE:APT) +24% Zoom Video and Peloton take off as new COVID variant revives stay-at-home trade Valneva SE (NASDAQ:VALN) +18...

HAUPPAUGE, N.Y., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostic Systems Inc. (“Chembio”), a subsidiary of Chembio Diagnostics, Inc. (Nasdaq: CEMI), received an international arbitration award Thursday, November 18, 2021 against BioSure (UK) Ltd, Chembio’s former U...

Shares of Chembio Diagnostics (NASDAQ:CEMI) are up 8% in after-hours trading after announcing that it has submitted an Emergency Use Authorization to the FDA for its DPP SARS-CoV-2 Antigen test. The test is designed to provide results in 20 minutes and use a minimally invasive nasal...

HAUPPAUGE, N.Y., Nov. 16, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced the submission of an Emergency Use Authorization (EUA) application to the U.S. Food and Drug Administ...